Evofem Biosciences, Inc. (NASDAQ:EVFM – Get Free Report)’s stock price passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $0.01 and traded as low as $0.0078. Evofem Biosciences shares last traded at $0.0085, with a volume of 317,881 shares trading hands.
Evofem Biosciences Trading Down 9.6%
The firm’s fifty day moving average is $0.01 and its 200 day moving average is $0.01. The company has a market cap of $1.13 million, a PE ratio of -0.01 and a beta of -1.33.
Evofem Biosciences Company Profile
Evofem Biosciences is a clinical?stage biotechnology company based in San Diego, California, specializing in women’s sexual and reproductive health. Founded in 2013 as a spin-out of the Scripps Research Institute, the company is focused on developing non-hormonal, on-demand products that address unmet needs in contraception and the prevention of sexually transmitted infections.
The company’s lead commercial product, Phexxi, is an FDA-approved, non-hormonal vaginal gel that maintains the vagina’s natural pH to reduce the risk of unintended pregnancy.
Recommended Stories
- Five stocks we like better than Evofem Biosciences
- Starbucks Builds Sovereign AI to Cut $400 Million in Software Costs
- Power Struggle: Wolfspeed Sues Navitas Over AI Chips
- Why WD-40 Is Proving Great Businesses Never Go Out of Style
- Pushing the Edge: Super Micro Computer Reboots the AI Landscape
Receive News & Ratings for Evofem Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evofem Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
